000 01284 a2200337 4500
005 20250514011542.0
264 0 _c20011204
008 200112s 0 0 eng d
022 _a1523-6838
024 7 _a10.1053/ajkd.2001.27391
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSunder-Plassmann, G
245 0 0 _aEffect of erythropoietin on cardiovascular diseases.
_h[electronic resource]
260 _bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_cOct 2001
300 _aS20-5 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnemia
_xdrug therapy
650 0 4 _aCardiovascular Diseases
_xepidemiology
650 0 4 _aComorbidity
650 0 4 _aErythropoietin
_xadverse effects
650 0 4 _aHematocrit
650 0 4 _aHumans
650 0 4 _aHypertension
_xchemically induced
650 0 4 _aIncidence
650 0 4 _aKidney Failure, Chronic
_xepidemiology
650 0 4 _aRecombinant Proteins
650 0 4 _aRenal Dialysis
700 1 _aHörl, W H
773 0 _tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_gvol. 38
_gno. 4 Suppl 1
_gp. S20-5
856 4 0 _uhttps://doi.org/10.1053/ajkd.2001.27391
_zAvailable from publisher's website
999 _c11498517
_d11498517